Popular Keywords
Drug Development & Delivery
Targeted drug delivery
Nanomedicine
Controlled release
Biodegradable polymers
Liposomes & nanoparticles
Editor-in-Chief
An Byung Chull
Editor-in-Chief
Department of Biomaterials engineering
Korea Atomic Energy Research Institute ,Korea
Biography
Dr. Byung Chull, An received his Ph.D. in Biomaterials engineering from The Korea University in 2010. He then conducted postdoctoral research with Dr. Mitsuo Ikebe at UMass Medical School from 2011 to 2013. He continued postdoctoral research fellowships at Korea Research Institute of Bioscience and Biotechnology and Chonnam national university before receiving a faculty position in R&D center at Cell Biotech, Co., Ltd.
Research Interest
Cancer cell pharmacology; anticancer drugs; drug resistance; predictive biomarkers; DNA damage response; cell signaling; tumor microenvironment; proteomic and bioinformatics approaches in cancer; oxidative stress; radiation therapy; radioresistance and radiation sensitizers; reactive oxygen species; DNA damage; thioredoxin/glutathione inhibitors; redox signaling
Journal Info
- Journal Name: Journal of Advanced Therapeutics
- ISSN: 3068-367X
- DOI: 10.52338/joat
- Short Name: Joat
- Acceptance rate: 55%
- Volume: 1 (2025)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility